Emerging targeted therapies in meningiomas
Emerging molecularly driven treatment strategies show promise for the treatment of patients with high-grade meningiomas. Larger trials that incorporate molecular testing are warranted to fully evaluate their therapeutic potential.
Authors
- Hiroaki Wakimoto (ORCID: https://orcid.org/0000-0001-8225-241X)
- Erika Yamazawa (ORCID: https://orcid.org/0000-0002-3079-2331)
- Priscilla Kaliopi Brastianos (ORCID: https://orcid.org/0000-0003-4470-8425)
- Emily Sullivan (ORCID: https://orcid.org/0009-0006-3767-7324)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Current Opinion in Neurology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1097/wco.0000000000001430
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00